The emerging role of paclitaxel in breast cancer therapy
- PMID: 9815979
The emerging role of paclitaxel in breast cancer therapy
Similar articles
-
Enhanced paclitaxel cytotoxicity and prolonged animal survival rate by a nonviral-mediated systemic delivery of E1A gene in orthotopic xenograft human breast cancer.Cancer Gene Ther. 2004 Sep;11(9):594-602. doi: 10.1038/sj.cgt.7700743. Cancer Gene Ther. 2004. PMID: 15272313
-
Synergistic therapy of breast cancer with Y-90-chimeric L6 and paclitaxel in the xenografted mouse model: development of a clinical protocol.Anticancer Res. 1998 Nov-Dec;18(6A):4011-8. Anticancer Res. 1998. PMID: 9891439
-
Single-agent paclitaxel in the treatment of breast cancer: phase I and II development.Semin Oncol. 1999 Jun;26(3 Suppl 8):14-20. Semin Oncol. 1999. PMID: 10403469 Review.
-
[Breast carcinoma. Preoperative chemotherapy can preserve the breast].MMW Fortschr Med. 2002 Oct 17;144(42):63. MMW Fortschr Med. 2002. PMID: 12534003 German. No abstract available.
-
The Fox Chase Cancer Center and Free University Hospital Investigators' Workshop and Consensus Conference on Paclitaxel. Part 1: Breast Cancer I.Semin Oncol. 1996 Oct;23(5 Suppl 11):1-70. Semin Oncol. 1996. PMID: 8966623 Review. No abstract available.
Cited by
-
Phase II study of paclitaxel in pretreated patients with locally advanced/metastatic cancer of the bladder and ureter.Br J Cancer. 1997;75(4):606-7. doi: 10.1038/bjc.1997.106. Br J Cancer. 1997. PMID: 9052419 Free PMC article. Clinical Trial.
-
New developments in cancer treatment with the novel thymidylate synthase inhibitor raltitrexed ('Tomudex').Br J Cancer. 1998;77 Suppl 2(Suppl 2):29-37. doi: 10.1038/bjc.1998.423. Br J Cancer. 1998. PMID: 9579853 Free PMC article. Review.
-
Once weekly paclitaxel associated with a fixed dose of oral metronomic cyclophosphamide: a dose-finding phase 1 trial.BMC Cancer. 2018 Jul 31;18(1):775. doi: 10.1186/s12885-018-4678-x. BMC Cancer. 2018. PMID: 30064401 Free PMC article. Clinical Trial.
-
Collection of circulating progenitor cells after epirubicin, paclitaxel and filgrastim in patients with metastatic breast cancer.Br J Cancer. 1997;75(9):1368-72. doi: 10.1038/bjc.1997.231. Br J Cancer. 1997. PMID: 9155060 Free PMC article.
-
SH003 enhances paclitaxel chemosensitivity in MCF-7/PAX breast cancer cells through inhibition of MDR1 activity.Mol Cell Biochem. 2017 Feb;426(1-2):1-8. doi: 10.1007/s11010-016-2875-y. Epub 2016 Nov 16. Mol Cell Biochem. 2017. PMID: 27854072
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical